Skip to main content
NCBI home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 1988 Apr;80(4):459–461.

Treatment of Myocardial Infarction: A Review

L Julian Haywood
PMCID: PMC2625749  PMID: 3290503

Abstract

An overview of the problems and management of acute myocardial infarction is presented. Certain factors that are pertinent to the problem of differential mortality in various population subgroups have been identified. These factors include race, sex, and socioeconomic background.

Full text

PDF
459

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. DeSilva R. A., Hennekens C. H., Lown B., Casscells W. Lignocaine prophylaxis in acute myocardial infarction: an evaluation of randomised trials. Lancet. 1981 Oct 17;2(8251):855–858. doi: 10.1016/s0140-6736(81)91116-8. [DOI] [PubMed] [Google Scholar]
  2. Ell K. O., Haywood L. J. Sociocultural factors in MI recovery: an exploratory study. Int J Psychiatry Med. 1985;15(2):157–175. doi: 10.2190/f1hv-tej0-y6ww-ykrh. [DOI] [PubMed] [Google Scholar]
  3. Ferlinz J. Nifedipine in myocardial ischemia, systemic hypertension, and other cardiovascular disorders. Ann Intern Med. 1986 Nov;105(5):714–729. doi: 10.7326/0003-4819-105-5-714. [DOI] [PubMed] [Google Scholar]
  4. Gunnar R. M., Loeb H. S. Shock in acute myocardial infarction: evolution of physiologic therapy. J Am Coll Cardiol. 1983 Jan;1(1):154–163. doi: 10.1016/s0735-1097(83)80019-9. [DOI] [PubMed] [Google Scholar]
  5. Haywood L. J. Coronary heart disease mortality/morbidity and risk in blacks. I: Clinical manifestations and diagnostic criteria: the experience with the Beta Blocker Heart Attack Trial. Am Heart J. 1984 Sep;108(3 Pt 2):787–793. doi: 10.1016/0002-8703(84)90672-0. [DOI] [PubMed] [Google Scholar]
  6. Haywood L. J. Coronary heart disease mortality/morbidity and risk in blacks. II: Access to medical care. Am Heart J. 1984 Sep;108(3 Pt 2):794–796. doi: 10.1016/0002-8703(84)90673-2. [DOI] [PubMed] [Google Scholar]
  7. Knoebel S. B. President's page: On the occasion of the 25th year of the Journal of the American College of Cardiology. J Am Coll Cardiol. 1983 Jan;1(1):1–2. doi: 10.1016/s0735-1097(83)80002-3. [DOI] [PubMed] [Google Scholar]
  8. Kuchar D. L., Thorburn C. W., Sammel N. L. Prediction of serious arrhythmic events after myocardial infarction: signal-averaged electrocardiogram, Holter monitoring and radionuclide ventriculography. J Am Coll Cardiol. 1987 Mar;9(3):531–538. doi: 10.1016/s0735-1097(87)80045-1. [DOI] [PubMed] [Google Scholar]
  9. Lie K. I., Wellens H. J., van Capelle F. J., Durrer D. Lidocaine in the prevention of primary ventricular fibrillation. A double-blind, randomized study of 212 consecutive patients. N Engl J Med. 1974 Dec 19;291(25):1324–1326. doi: 10.1056/NEJM197412192912504. [DOI] [PubMed] [Google Scholar]
  10. Lown B., Fakhro A. M., Hood W. B., Jr, Thorn G. W. The coronary care unit. New perspectives and directions. JAMA. 1967 Jan 16;199(3):188–198. [PubMed] [Google Scholar]
  11. Maekawa K., Liang C. S., Hood W. B., Jr Comparison of dobutamine and dopamine in acute myocardial infarction. Effects of systemic hemodynamics, plasma catecholamines, blood flows and infarct size. Circulation. 1983 Apr;67(4):750–759. doi: 10.1161/01.cir.67.4.750. [DOI] [PubMed] [Google Scholar]
  12. Mathey D. G., Sheehan F. H., Schofer J., Dodge H. T. Time from onset of symptoms to thrombolytic therapy: a major determinant of myocardial salvage in patients with acute transmural infarction. J Am Coll Cardiol. 1985 Sep;6(3):518–525. doi: 10.1016/s0735-1097(85)80107-8. [DOI] [PubMed] [Google Scholar]
  13. Maynard C., Fisher L. D., Passamani E. R., Pullum T. Blacks in the coronary artery surgery study (CASS): race and clinical decision making. Am J Public Health. 1986 Dec;76(12):1446–1448. doi: 10.2105/ajph.76.12.1446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Miller H. I., Almagor Y., Keren G., Chernilas J., Roth A., Eschar Y., Shapira I., Shargorodsky B., Berenfeld D., Laniado S. Early intervention in acute myocardial infarction: significance for myocardial salvage of immediate intravenous streptokinase therapy followed by coronary angioplasty. J Am Coll Cardiol. 1987 Mar;9(3):608–614. doi: 10.1016/s0735-1097(87)80055-4. [DOI] [PubMed] [Google Scholar]
  15. Muller J. E., Morrison J., Stone P. H., Rude R. E., Rosner B., Roberts R., Pearle D. L., Turi Z. G., Schneider J. F., Serfas D. H. Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison. Circulation. 1984 Apr;69(4):740–747. doi: 10.1161/01.cir.69.4.740. [DOI] [PubMed] [Google Scholar]
  16. Pantridge J. F., Geddes J. S. Diseases of the cardiovascular system. Management of acute myocardial infarction. Br Med J. 1976 Jul 17;2(6028):168–170. doi: 10.1136/bmj.2.6028.168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Wyman M. G., Hammersmith L. Comprehensive treatment plan for the prevention of primary ventricular fibrillation in acute myocardial infarction. Am J Cardiol. 1974 May 6;33(5):661–667. doi: 10.1016/0002-9149(74)90259-8. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES